An experimental drug developed out of Norway gains momentum including FDA Fast Track, and its maker, BerGenBio ASA, selected drug development and contract drug manufacturer Piramal Pharma The investigational candidate, bemcentinib, was recently designated by the U.S....
It used to be a reality that if one was diagnosed with cancer and lived in Connecticut or rural communities surrounding the New York City metropolitan area, that to participate in an advanced clinical trial, they would more than likely have had to commute to New York...
The BC Cancer Foundation helps move the dial on cancer research and care in British Columbia. And this support is surely important as one in two British Columbians will face cancer in their lifetime reports Coast Mountain News. The expert investigators at BC Cancer...
Young Dana-Farber investigators Jennifer Guerriero, PhD and Sarah Hill, MD, PhD are on a mission to find better treatments for breast, ovarian and other cancers. Their research depends on patient tissue samples obtained by surgeons in Dana-Farber’s Susan F. Smith...
Professor Laurence Klotz, one of the clinical investigators working on LIDDS’ LPC-004 study, recently summarized the results at the 11th European Multidisciplinary Congress on Urological Cancers (EMUC 19). Professor Klotz presented the Phase IIb clinical data from the...
Recently Karen E. Knudsen, Ph.D., enterprise director at the Sidney Kimmel Cancer Center, Jefferson Health, wrote an editorial as to whether a clinical trial is a right thing to do for a patient. Ms. Knudsen oversees cancer care and cancer research at all SKCC sites...
